Vyome Therapeutics is a biopharmaceutical company engaged in the development of novel drugs for antibiotic-resistant acne and other opportunist pathogens.
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
Faraday Pharmaceuticals is a company specializing in the use of elemental reducing agents to support the quality of life after acute, critical illness.
Aurealis Therapeutics (formerly known as Aurealis Pharma) is a biopharmaceutical company developing medicines for the treatment of cancer and chronic wounds.